Table 4.
Frequency and ORs of 12-month mortality by jurisdiction and emergency presentation status across patients with any of the studied eight cancers
| Number of patients | Number of 12-month mortalities* | Crude OR (95% CI)† | Adjusted (stage-unadjusted) OR (95% CI)† | Stage-adjusted OR (95% CI)† | |
|---|---|---|---|---|---|
| Denmark§ | |||||
| Non-EP | 31 804 | 9013 (28·3%) | (ref) | (ref) | (ref) |
| EP | 14 199 | 8597 (60·5%) | 3·88 (3·72–4·05) | 3·28 (3·13–3·43) | 2·62 (2·49–2·76) |
| Norway‡ | |||||
| Non-EP | 29 281 | 7222 (24·7%) | (ref) | (ref) | (ref) |
| EP | 16 866 | 10 107 (59·9%) | 4·57 (4·39–4·76) | 4·37 (4·17–4·58) | 3·31 (3·15–3·49) |
| England§ | |||||
| Non-EP | 256 260 | 99 437 (38·8%) | (ref) | (ref) | (ref) |
| EP | 116 934 | 88 261 (75·5%) | 4·85 (4·78–4·93) | 4·54 (4·46–4·62) | 3·46 (3·39–3·53) |
| Northern Ireland§ | |||||
| Non-EP | 11 179 | 4328 (38·7%) | (ref) | (ref) | (ref) |
| EP | 4322 | 3380 (78·2%) | 5·68 (5·24–6·17) | 5·46 (4·98–5·99) | 3·53 (3·19–3·92) |
| Scotland‡ | |||||
| Non-EP | 27 708 | 10 910 (39·4%) | (ref) | (ref) | (ref) |
| EP | 17 321 | 12 507 (72·2%) | 4·00 (3·84–4·17) | 3·60 (3·44–3·77) | 2·95 (2·80–3·11) |
| Wales‡ | |||||
| Non-EP | 16 376 | 6253 (38·2%) | (ref) | (ref) | (ref) |
| EP | 9763 | 7017 (71·9%) | 4·14 (3·92–4·37) | 3·79 (3·57–4·03) | 2·99 (2·79–3·19) |
| Albertaঠ| |||||
| Non-EP | 17 741 | 5599 (31·6%) | (ref) | (ref) | (ref) |
| EP | 7441 | 4839 (65·0%) | 4·03 (3·81–4·27) | 3·86 (3·62–4·12) | 2·63 (2·45–2·83) |
| Atlantic Canadaঠ| |||||
| Non-EP | 8065 | 2745 (34·0%) | (ref) | (ref) | (ref) |
| EP | 2905 | 1855 (63·9%) | 3·42 (3·13–3·74) | 3·79 (3·42–4·21) | 2·74 (2·44–3·08) |
| British Columbia‡¶‖ | |||||
| Non-EP | 11 295 | 3555 (31·5%) | (ref) | (ref) | (ref) |
| EP | 5195 | 3320 (63·9%) | 3·84 (3·59–4·12) | 4·01 (3·70–4·36) | 3·11 (2·85–3·39) |
| Ontario‡ | |||||
| Non-EP | 68 316 | 20 197 (29·6%) | (ref) | (ref) | (ref) |
| EP | 24 131 | 14 623 (60·6%) | 3·66 (3·55–3·78) | 3·87 (3·74–4·00) | 2·95 (2·84–3·06) |
| Saskatchewan-Manitobaঠ| |||||
| Non-EP | 5985 | 1955 (32·7%) | (ref) | (ref) | (ref) |
| EP | 2400 | 1520 (63·3%) | 3·57 (3·24–3·95) | 3·77 (3·36–4·24) | 2·72 (2·39–3·09) |
| New South Wales§ | |||||
| Non-EP | 36 753 | 9663 (26·3%) | (ref) | (ref) | (ref) |
| EP | 16 445 | 9836 (59·8%) | 4·17 (4·01–4·34) | 3·74 (3·58–3·91) | 2·89 (2·75–3·03) |
| Victoria§‖ | |||||
| Non-EP | 29 047 | 7557 (26·0%) | (ref) | (ref) | (ref) |
| EP | 9165 | 5328 (58·1%) | 3·95 (3·76–4·15) | 3·70 (3·50–3·92) | 3·33 (3·15–3·53) |
| New Zealand‡ | |||||
| Non-EP | 16 556 | 4653 (28·1%) | (ref) | (ref) | (ref) |
| EP | 12 238 | 7572 (61·9%) | 4·15 (3·95–4·36) | 3·73 (3·53–3·95) | 2·57 (2·42–2·74) |
Adjusted ORs for emergency presentation estimated after adjustment for other variables other than stage (ie, including cancer site, age group, and sex; but without adjustment for stage), and then including all variables and including stage at diagnosis (stage adjusted; appendix pp 45–58). EP=emergency presentation. OR=Odds ratio. ref=reference group.
For 95% CIs for mortality proportions see appendix pp 45–58.
p values for all OR values shown are p<0·0001.
Broad operational definition was used.
Narrow operational definition was used.
Data for these jurisdictions relate to cancer cases diagnosed in 2012 and 2013.
Victoria and British Columbia did not contribute stage data across all cancer sites; see appendix (p 12) for missing stage data by jurisdiction.